Literature DB >> 10783125

Bleomycin-mediated pulmonary toxicity: evidence for a p53-mediated response.

A Mishra1, N A Doyle.   

Abstract

Bleomycin damages DNA and causes lung injury and fibrosis. To determine whether bleomycin is associated with the appearance of DNA damage-inducible proteins, C3H mice received either 0.4 mg bleomycin or normal saline intratracheally and were killed 1 to 14 d later. The lungs were examined for expression of p53, p21(WAF1/PiCl), and proliferating cell nuclear antigen (PCNA) using immunohistochemistry and Western blotting. p53-positive cells first appeared at 5 d after treatment and peaked at 7 d; PCNA-positive cells appeared at 1 d after treatment and peaked at 7 d; and p21-positive cells appeared at 5 d and peaked at 9 d. Western blot analysis confirmed that bleomycin upregulated the DNA damage-inducible proteins in a similar fashion. This is the first evidence that bleomycin causes a p53-dependent response associated with acute injury in the lung.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10783125     DOI: 10.1165/ajrcmb.22.5.3851

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  18 in total

1.  Regulation of alveolar epithelial cell apoptosis and pulmonary fibrosis by coordinate expression of components of the fibrinolytic system.

Authors:  Yashodhar P Bhandary; Shwetha K Shetty; Amarnath S Marudamuthu; Margaret R Gyetko; Steven Idell; Mehrnaz Gharaee-Kermani; Rashmi S Shetty; Barry C Starcher; Sreerama Shetty
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-12-02       Impact factor: 5.464

2.  Regulation of urokinase receptor expression by p53: novel role in stabilization of uPAR mRNA.

Authors:  Sreerama Shetty; Thirunavukkarasu Velusamy; Steven Idell; Praveenkumar Shetty; Andrew P Mazar; Yashodhar P Bhandary; Rashmi S Shetty
Journal:  Mol Cell Biol       Date:  2007-06-04       Impact factor: 4.272

3.  Radiation induced pulmonary fibrosis as a model of progressive fibrosis: Contributions of DNA damage, inflammatory response and cellular senescence genes.

Authors:  Tyler A Beach; Carl J Johnston; Angela M Groves; Jacqueline P Williams; Jacob N Finkelstein
Journal:  Exp Lung Res       Date:  2017-05-23       Impact factor: 2.459

4.  Direct leukocyte migration across pulmonary arterioles and venules into the perivascular interstitium of murine lungs during bleomycin injury and repair.

Authors:  Ping M Wang; Diane L Kachel; Mark F Cesta; William J Martin
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

5.  Epithelial Deletion of Sulf2 Exacerbates Bleomycin-Induced Lung Injury, Inflammation, and Mortality.

Authors:  Xinping Yue
Journal:  Am J Respir Cell Mol Biol       Date:  2017-11       Impact factor: 6.914

6.  Bleomycin induces the extrinsic apoptotic pathway in pulmonary endothelial cells.

Authors:  Ognoon Mungunsukh; Autumn J Griffin; Young H Lee; Regina M Day
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-02-12       Impact factor: 5.464

7.  Regulation of plasminogen activator inhibitor-1 expression by tumor suppressor protein p53.

Authors:  Sreerama Shetty; Praveenkumar Shetty; Steven Idell; Thirunavukkarasu Velusamy; Yashodhar P Bhandary; Rashmi S Shetty
Journal:  J Biol Chem       Date:  2008-05-09       Impact factor: 5.157

8.  Normal remodeling of the oxygen-injured lung requires the cyclin-dependent kinase inhibitor p21(Cip1/WAF1/Sdi1).

Authors:  Rhonda J Staversky; Richard H Watkins; Terry W Wright; Eric Hernady; Michael B LoMonaco; Carl T D'Angio; Jacqueline P Williams; William M Maniscalco; Michael A O'Reilly
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

9.  P21 regulates TGF-beta1-induced pulmonary responses via a TNF-alpha-signaling pathway.

Authors:  Masashi Yamasaki; Hye-Ryun Kang; Robert J Homer; Svetlana P Chapoval; Soo Jung Cho; Byung Jae Lee; Jack A Elias; Chun Geun Lee
Journal:  Am J Respir Cell Mol Biol       Date:  2007-10-11       Impact factor: 6.914

10.  Drug induced interstitial lung disease.

Authors:  Martin Schwaiblmair; Werner Behr; Thomas Haeckel; Bruno Märkl; Wolfgang Foerg; Thomas Berghaus
Journal:  Open Respir Med J       Date:  2012-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.